Understanding of all relevant FDA guidance pertaining to 505(b)(2) products development
Literature search focusing preclinical and clinical development programme
Understanding and defining the rationale of unmet need for identified product
Thorough understanding of disease physiology, preclinical safety pharmacology.
Identifying appropriate CRO for conducting non-clinical POC, Toxicity, safety pharmacology studies, PK/PD studies in human, bioequivalence/bioavailability studies.
Budgeting of preclinical and clinical studies
Authoring and review of study plan, protocol, scientific justification, publication for non-clinical studies.
Review the data of preclinical POC, bioavailability and bioequivalence studies and leading the discussion with different cross functional team and CRO.
Authoring and review of clinical, non-clinical sections in IND, briefing package, Investigators Brochure and NDA for regulatory submission.